About Us

At 108 BioCapital, we are dedicated to advancing the frontiers of medical innovation. Our mission is to invest in transformative healthcare solutions that address urgent unmet medical needs, improve patient outcomes, and deliver sustained value to our investors.

The US healthcare and medtech sectors present an extraordinary growth opportunity, with healthcare spending projected to reach 20% of GDP by 2032. Advances in diagnostics, therapeutic devices, and personalized medicine are reshaping the industry. We seek to partner with visionary entrepreneurs and management teams, leveraging our expertise and network to accelerate growth and maximize impact.

The information on this website is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Investments are offered only to accredited investors through a confidential private placement memorandum and related documents. All investments involve risk, including the possible loss of principal. Past performance is not indicative of future results.